Trial intelligence / Profile preview

Combination Antiretroviral Therapy Regimens in Treatment Naive Patients With Advanced HIV Disease

NCT00342355Phase 4Completed

Sponsor
National Institutes of Health
Start
Jan 2004
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of zidovudine, didanosine, efavirenz, lopinavir + ritonavir, stavudine in human immunodeficiency virus infection (HIV), sponsored by National Institutes of Health. Started Jan 2004; status: completed.

02

Drugs

zidovudinedidanosineefavirenzlopinavir + ritonavirstavudine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00342355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00342355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call